Stocksigma LogoStocksigma Logo

NCLAT Sets Aside CIRP Order Against Shilpa Medicare Subsidiary FTF Pharma

NCLAT, vide its order dated 4th Nov'26, set aside the NCLT Ahmedabad Bench order dated 9th Sep'26 that had initiated Corporate Insolvency Resolution

NCLAT Sets Aside CIRP Order Against Shilpa Medicare Subsidiary FTF Pharma

Shilpa Medicare Ltd 路 Others (Uncategorized) 路 05 Nov 2026, 10:14 pm

NCLAT Sets Aside CIRP Order Against Shilpa Medicare Subsidiary FTF Pharma NCLAT, vide its order dated 4th Nov'26, set aside the NCLT Ahmedabad Bench order dated 9th Sep'26 that had initiated Corporate Insolvency Resolution Process (CIRP) against FTF Pharma Private Limited, a wholly owned subsidiary of Shilpa Medicare Limited. The Section 9 application filed by operational creditor Immacule Lifesciences for Rs 2.18 cr was rejected due to pre-existing disputes and mutual resolution. Consequently, the CIRP and Section 14 moratorium stand annulled, the Interim Resolution Professional is discharged, and management control is restored with zero financial impact on Shilpa Medicare.

Original exchange filing (PDF)

More announcements from Shilpa Medicare Ltd

All Shilpa Medicare Ltd announcements